{"id":321297,"date":"2026-10-21T16:48:02","date_gmt":"2026-10-21T11:18:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=321297"},"modified":"2026-10-21T16:48:02","modified_gmt":"2026-10-21T11:18:02","slug":"should-you-buy-vedanta-shares-after-hindustan-zinc-beats-q2-estimates-emkay-buy-target-350","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/should-you-buy-vedanta-shares-after-hindustan-zinc-beats-q2-estimates-emkay-buy-target-350\/","title":{"rendered":"Vedanta Shares: Should You Buy After Hindustan Zinc Beats Q2 Estimates? Emkay Keeps Buy and a Rs 350 Target"},"content":{"rendered":"

Emkay Global kept its Buy rating on Vedanta with an unchanged target of Rs 350 after subsidiary Hindustan Zinc reported a 142% rise in Q2 FY27 profit to Rs 6,412 crore on 19 Oct 2026. Vedanta shares traded at Rs 236.85 on 21 Oct (down 2.61%), so the target is about 47.8% above the price (my calculation). Hindustan Zinc itself opened about 4% higher on 21 Oct and then fell to Rs 525.00, down 2.49%. Emkay’s valuation method was not stated in the report I read, and the target is a broker view and not a promise.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Vedanta shares are rated Buy by Emkay Global with an unchanged target price of Rs 350, kept after Hindustan Zinc reported Q2 FY27 net profit of Rs 6,412 crore, up 142% from Rs 2,649 crore, and a record EBITDA of about Rs 9,285 crore. Emkay says Hindustan Zinc is about 90% of Vedanta’s FY27 EBITDA, so the earnings beat feeds straight into Vedanta, and it sees more upside if zinc and silver prices stay near spot levels. At Rs 236.85 on 21 Oct the Emkay target is about 47.8% above the price (my calculation), but Vedanta shares fell 2.61% on the day even after the results, and the report did not state how the target was valued. Whether to buy depends on your view of zinc and silver prices, the group’s structure and your own risk limit, so treat the call as one input and not as advice.<\/p>\n<\/p><\/div>\n

Vedanta shares moved lower on 21 Oct 2026 even though the main earnings driver, Hindustan Zinc, posted a record quarter. Hindustan Zinc’s Q2 FY27 results on 19 Oct showed profit up 142%, revenue up about 77% and a zinc production cost that fell 29% year on year, and the stock opened about 4% higher on Wednesday before selling off.<\/p>\n

This article on Vedanta shares covers the Hindustan Zinc results, Emkay’s Buy call and what it assumes, how Vedanta shares and Hindustan Zinc trade today, the other broker views, the risks and what to check before you buy. It is educational and not a recommendation to buy or sell any share.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n